![](/img/cover-not-exists.png)
P-051Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA)
Pericay, C., Martínez-Lago, N., Corral, M., Macías Declara, I., Donnay, O., Juez Martel, I., García-Paredes, B., Méndez Méndez, J.C., Cacho Lanvin, D., González-Astorga, B., Ruiz Casado, A., Delgado UVolume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw199.49
Date:
June, 2016
File:
PDF, 67 KB
2016